|
phenotypic sex
|
PATO_0001894 |
|
|
biological sex
|
PATO_0000047 |
|
|
realizable entity
|
BFO_0000017 |
|
|
continuant
|
BFO_0000002 |
|
|
entity
|
BFO_0000001 |
|
|
occurrent
|
BFO_0000003 |
|
|
Thing
|
Thing |
|
|
human subjects protection review board status
|
CTO_0000040 |
|
|
retrospective study design
|
CTO_0000044 |
|
|
phase not applicable
|
CTO_0000043 |
|
|
Korean clinical trials registry
|
CTO_0000041 |
|
|
UMIN clinical trials registry
|
CTO_0000037 |
|
|
EU clinical trials register
|
CTO_0000036 |
|
|
primary outcome measure information
|
CTO_0000035 |
|
|
outcome specification
|
CTO_0000051 |
|
|
age_between_birth_and_17_years
|
CTO_0000034 |
|
|
outcome measure result
|
CTO_0000039 |
|
|
report
|
IAO_0000088 |
|
|
age_older_than_64
|
CTO_0000038 |
|
|
spatial region
|
BFO_0000006 |
|
